Boosters Become Big Pharma Free-for-All With More Shots Coming (1)

March 21, 2022, 2:58 PM UTC

The omicron wave is finally on the decline in the U.S. Workers are returning to offices again, hospital wards are emptying, and states have lifted mask mandates. But a new strain, BA.2, has spread widely in Europe and is growing in prevalence in the U.S. And Pfizer Inc. and Moderna Inc. have now asked U.S. regulators to clear an additional Covid-19 booster as protection provided by the first three shots fades.

While the vaccines at first were remarkably good at preventing Covid infections, successive mutations and the passage of time have rendered the shots less effective. The boosters ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.